Outcome of the 2/2025-26 Meeting of the Board of Directors of the Company held on Friday, 08th August 2025 pursuant to Regulation 30 read with Schedule III(A)(IV) of the SEBI(LODR) Regulations, 2015.

pdf

Syncom Formulation (India) Ltd.

08 Aug 2025

17.67

-0.17%

Result

Syncom Formulations India Ltd-$ - 524470 - Results- Financial Results 30.06.2025

BSE India

Regulation 33(3) of SEBI LODR REG, 2015, Submission of unaudited Standalone and Consolidated financials for the quarter ended 30.06.2025

pdf

	Jun 2025	Mar 2025	Jun 2024	Change QoQ%	Change YoY%
Total Revenue Qtr	122.94	155.82	88.59	-21.1%	38.8%
Operating Profit Qtr	15.81	17.75	10.45	-10.9%	51.3%
Net Profit Qtr	15.75	17.69	7.63	-11.0%	106.4%
Earning Per Share Adjusted latest Qtr	0.17	0.19	0.08	-10.5%	112.5%

* Consolidated data

Detailed Results

Syncom Formulation (India) Ltd.

02 Aug 2025

17.67

-0.17%

Board Meeting

Syncom Formulations India Ltd-$ - 524470 - Board Meeting Intimation for Corporate Announcement U/R 29(1)(A) Of …

BSE India

Syncom Formulations India Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2025 ,inter alia, to consider and approve 2/2025-26 Meeting of the Board of Directors of the Company is scheduled to be held on Friday the 8th day of August, 2025 at 4:00 P.M. at the Corporate Office situated at 207, Saket Nagar, Near Saket Club Indore (M.P.) 452018 to consider and approve the following businesses along with other routine businesses: a) To consider and approve Standalone and Consolidated Unaudited Financial Results of the Company for the Quarter ended 30th June, 2025; b) To take on record the Standalone and Consolidated Limited Review Report by Auditors for the Unaudited Financial Results of the Company for the Quarter ended 30th June, 2025. c) To consider and approve other matter.

pdf

Syncom Formulation (India) Ltd.

17 Jul 2025

17.67

-0.17%

Company Update

Syncom Formulations India Ltd-$ - 524470 - Dispatch Of KYC Letters To Shareholders Requiring Copy Of …

BSE India

Pursuant to SEBI Circular No.SEBI/HO/MIRSD/POD-1/P/CIR/2024/37 date May 7, 2024, we would like to inform that, Registrar & Share Transfer agent M/s Ankit Consultancy Pvt. Ltd. is in process of dispatch of the letter to the shareholder related to mandatory furnishing of PAN , Choice of Nomination, Contact Details, Mobile Number, Bank Account Details and Specimen Signature

pdf

Is Syncom Formulation (India) Ltd. worth buying?

898 Votes:

Buy 83.85%

Sell 8.02%

Hold 8.13%